Health Condition 1: C169- Malignant neoplasm of stomach, unspecified
Conditions
Interventions
Intervention1: Gold Directed Fluid Therapy: Gold Directed Fluid Therapy using flotrac/vigileo. THis monitoring will be done throughout the surgery and in the post-operative period in ICU.
Control Inte
Sponsors
AIIMS, New Delhi
Eligibility
Inclusion criteria
Inclusion criteria: 1. Agree to participate in the study and sign written informed consent. 2. ASA-PS grade I /II or III patients posted for CRS and HIPEC surgery.
Exclusion criteria
Exclusion criteria: 1.Known case of liver dysfunction or renal dysfunction 2.Known coagulation disorder 3.COPD with FEV1 4.Left Ventricular Ejection Fraction 5.Allergic to any drug used during the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Post-operative Renal complications in terms of AKIN classification and improvement in AKITimepoint: At baseline and immediately after surgery and 24 hrs post-surgery. | — |
Secondary
| Measure | Time frame |
|---|---|
| a) Intraoperative and post-operative serum lactate levels. b) Post-operative length of stay in the Intensive Care Unit (ICU) until the patient is deemed fit for discharge. c) 30-day mortality rate after the surgery.Timepoint: a) 24 hours c) 30 days | — |
Countries
India
Contacts
Public ContactDr Raghav Gupta
All India Institute of Medical Sciences (AIIMS)
Outcome results
None listed